Physician profile
Robert G Sorrell
NPI 1205876927
$9,320.36
in general payments reported to CMS, 2019-2025
30 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,344 · 2020: $883 · 2021: $201 · 2022: $293 · 2023: $2,543 · 2024: $1,412 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,740 · Food and Beverage: $1,568 · Travel and Lodging: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,740.00 |
| Food and Beverage | $1,568.20 |
| Travel and Lodging | $1,290.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prime Surgical, LLC | $3,927.62 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $1,740.00 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $1,259.47 | 2023-2025 | Zilretta, Exparel, Iovera |
| Zimmer Biomet Holdings, INC. | $966.36 | 2022-2025 | Avenir, Persona, Rosa |
| Depuy Synthes Sales INC. | $498.81 | 2019-2025 | Dynacord, Healix Knotless Peek, Dynatape |
| Orthalign INC | $147.32 | 2025 | Orthalign Plus |
| Ethicon US, LLC | $106.09 | 2024 | Stratafix, Vistaseal, Dermabond Prineo |
| Pacira Therapeutics, INC. | $95.03 | 2020-2021 | |
| Bioventus LLC | $57.80 | 2019-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Baxter Healthcare | $52.57 | 2019-2020 | |
| Boston Scientific Corporation | $43.84 | 2020-2021 | |
| Smith+Nephew, INC. | $43.79 | 2023 | Journey II |
| Convatec INC. | $41.68 | 2021-2025 | |
| Heraeus Medical, LLC. | $41.06 | 2020 | |
| Abbott Laboratories | $38.48 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $33.31 | 2019-2021 | |
| Si-Bone, INC. | $27.79 | 2019-2021 | |
| Solventum Corporation | $27.52 | 2025 | Prevena, V.A.C. Veraflo |
| Fidia Pharma USA INC. | $22.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.87 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.96 | 2025 | |
| Heron Therapeutics, INC. | $17.68 | 2021 | |
| Ermi LLC | $17.01 | 2025 | |
| Kyowa Kirin, INC. | $16.62 | 2022 | |
| Sanara Medtech INC. | $15.44 | 2022 | |
| Baudax Bio INC. | $14.55 | 2021 | |
| Orthofix Medical, INC. | $13.76 | 2023 | Physio-Stim |
| Zyla Life Sciences, INC. | $11.14 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sorrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.